A systematic review of intervention thresholds based on FRAX

NCCN Task Force Report: Bone Health in Cancer Care

(2017) Julie R. Gralow et al.   Journal of the National Comprehensive Cancer Network

Adjusting Hip Fracture Probability in Men and Women Using Hip Axis Length: the Manitoba Bone Density Database

(2016) William D. Leslie et al.   JOURNAL OF CLINICAL DENSITOMETRY

Evaluation and Management of Skeletal Health in Celiac Disease: Position Statement

(2016) Mona A Fouda et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society

(2015) Yousef Al-Saleh et al.   ANNALS OF SAUDI MEDICINE

The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis

(2015) Andréa Marques et al.   ANNALS OF THE RHEUMATIC DISEASES

Is There an Interaction Between Socioeconomic Status and FRAX 10-Year Fracture Probability Determined With and Without Bone Density Measures? Data from the Geelong Osteoporosis Study of Female Cohort

(2015) S. L. Brennan et al.   CALCIFIED TISSUE INTERNATIONAL

SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture

(2015) John A. Kanis et al.   CALCIFIED TISSUE INTERNATIONAL

Adjusting Fracture Probability by Trabecular Bone Score

(2015) Eugene V. McCloskey et al.   CALCIFIED TISSUE INTERNATIONAL

Intervention Thresholds and the Diagnosis of Osteoporosis

(2015) John A Kanis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX

(2015) Eugene V McCloskey et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice

(2015) Georgios Kyriakos et al.   JOURNAL OF CLINICAL DENSITOMETRY

Umbrales de FRAX® para identificar personas con alto o bajo riesgo de fractura osteoporótica en población femenina española

(2015) Rafael Azagra et al.   MEDICINA CLINICA

Is the Swedish FRAX model appropriate for Swedish immigrants?

(2015) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

FRAX-based assessment and intervention thresholds—an exploration of thresholds in women aged 50 years and older in the UK

(2015) E. McCloskey et al.   OSTEOPOROSIS INTERNATIONAL

FRAX predicts incident falls in elderly men: findings from MrOs Sweden

(2015) N. C. Harvey et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effective osteoporosis treatment thresholds in Greece

(2015) P. Makras et al.   OSTEOPOROSIS INTERNATIONAL

Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density

(2015) S. Nayak et al.   OSTEOPOROSIS INTERNATIONAL

US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50–64 years

(2015) S. Bansal et al.   OSTEOPOROSIS INTERNATIONAL

Assessment and management of fracture risk in patients with Parkinson's disease

(2014) Veronica Lyell et al.   AGE AND AGEING

Bone health in cancer patients: ESMO Clinical Practice Guidelines

(2014) R. Coleman et al.   ANNALS OF ONCOLOGY

Managing osteoporosis with FRAX® in Australia: Proposed new treatment thresholds from the 45&Up Study cohort

(2014) Jian Sheng Chen et al.   BONE

Evaluation of the FRAX Model for Hip Fracture Predictions in the Population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE)

(2014) Reijo Sund et al.   CALCIFIED TISSUE INTERNATIONAL

Impact of Femoral Neck and Lumbar Spine BMD Discordances on FRAX Probabilities in Women: A Meta-analysis of International Cohorts

(2014) H. Johansson et al.   CALCIFIED TISSUE INTERNATIONAL

Osteoporosis Screening in Postmenopausal Women 50 to 64 Years Old: Comparison of US Preventive Services Task Force Strategy and Two Traditional Strategies in the Women's Health Initiative

(2014) Carolyn J Crandall et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Clinician’s Guide to Prevention and Treatment of Osteoporosis

(2014) F. Cosman et al.   OSTEOPOROSIS INTERNATIONAL

Lumbar spine texture enhances 10-year fracture probability assessment

(2014) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

Worldwide uptake of FRAX

(2014) J. A. Kanis et al.   Archives of Osteoporosis

Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians

(2013) Amir Qaseem et al.   ANNALS OF INTERNAL MEDICINE

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

(2013) N Duru et al.   ANNALS OF THE RHEUMATIC DISEASES

Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal women

(2013) Elaine Cheung et al.   CLINICAL ENDOCRINOLOGY

The Malaysian Clinical Guidance on the Management of Postmenopausal Osteoporosis, 2012: A Summary

(2013) Swan S. Yeap et al.   International Journal of Rheumatic Diseases

Application of the fracture risk assessment tool (FRAX®) and determination of suitable cut-off values during primary screening in specific health check-ups in Japan

(2013) Shinichi Nakatoh et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Consensus of Official Position of IOF/ISCD FRAX Initiatives in Asia-Pacific Region

(2013) Chih-Hsing Wu et al.   JOURNAL OF CLINICAL DENSITOMETRY

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013

(2013) J. Compston et al.   MATURITAS

FRAX provides robust fracture prediction regardless of socioeconomic status

(2013) S. L. Brennan et al.   OSTEOPOROSIS INTERNATIONAL

Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?

(2013) A. Scillitani et al.   OSTEOPOROSIS INTERNATIONAL

Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data

(2013) J. W. Kim et al.   OSTEOPOROSIS INTERNATIONAL

Comparison between various fracture risk assessment tools

(2013) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

FRAX-based intervention and assessment thresholds for osteoporosis in Romania

(2013) Daniel Grigorie et al.   Archives of Osteoporosis

Osteoporosis among older Saudis: risk of fractures and unmet needs

(2013) Tarek Tawfik Amin et al.   Archives of Osteoporosis

Development and application of FRAX in the management of osteoporosis in Ireland

(2013) B McGowan et al.   Archives of Osteoporosis

Sri Lankan FRAX model and country-specific intervention thresholds

(2013) Sarath Lekamwasam   Archives of Osteoporosis

SCOPE: a scorecard for osteoporosis in Europe

(2013) J. A. Kanis et al.   Archives of Osteoporosis

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort

(2012) Rafael Azagra et al.   BMC MUSCULOSKELETAL DISORDERS

Assessing the Impact of Osteoporosis on the Burden of Hip Fractures

(2012) Anders Odén et al.   CALCIFIED TISSUE INTERNATIONAL

2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis

(2012) Karine Briot et al.   JOINT BONE SPINE

The distribution of FRAX®-based probabilities in women from Japan

(2012) John A. Kanis et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)

(2012) Yoshiki Nishizawa et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Does osteoporosis therapy invalidate FRAX for fracture prediction?

(2012) William D Leslie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline

(2012) Nelson B. Watts et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pitfalls in the external validation of FRAX: response to Bolland et al.

(2012) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: rationale, design and methods for the SCOOP study

(2012) L. Shepstone et al.   OSTEOPOROSIS INTERNATIONAL

Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper

(2012) R. Rizzoli et al.   OSTEOPOROSIS INTERNATIONAL

A comparison of case-finding strategies in the UK for the management of hip fractures

(2012) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study

(2012) B. Ettinger et al.   OSTEOPOROSIS INTERNATIONAL

Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis

(2012) O. Ström et al.   OSTEOPOROSIS INTERNATIONAL

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

(2012) S. Lekamwasam et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland

(2012) K. Lippuner et al.   OSTEOPOROSIS INTERNATIONAL

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2012) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

A systematic review of hip fracture incidence and probability of fracture worldwide

(2012) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Suppression androgénique dans le cancer de la prostate et risque ostéoporotique

(2012) B. Cortet et al.   PROGRES EN UROLOGIE

Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX® criteria

(2012) O. Bruyère et al.   RHEUMATOLOGY INTERNATIONAL

Risk assessment of fragility fractures: summary of NICE guidance

(2012) S. Rabar et al.   BMJ-British Medical Journal

Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study

(2012) J. Hippisley-Cox et al.   BMJ-British Medical Journal

Diretrizes para prevenção e tratamento da osteoporose induzida por glicocorticoide

(2012) Rosa Maria Rodrigues Pereira et al.   Revista Brasileira De Reumatologia

Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary

(2012) Hajime Orimo et al.   Archives of Osteoporosis

Epidemiology of fracture in the Russian Federation and the development of a FRAX model

(2012) Olga Lesnyak et al.   Archives of Osteoporosis

Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales

(2012) Rebeca Reyes García et al.   Endocrinologia y Nutricion

FRAX® with and without Bone Mineral Density

(2011) John A. Kanis et al.   CALCIFIED TISSUE INTERNATIONAL

Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines

(2011) Julie LI-YU et al.   International Journal of Rheumatic Diseases

Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes

(2011) Ann V. Schwartz   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Novel methods to evaluate fracture risk models

(2011) Meghan G Donaldson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

WHO absolute fracture risk models (FRAX): Do clinical risk factors improve fracture prediction in older women without osteoporosis?

(2011) Teresa A Hillier et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FRAX® International Task Force of the 2010 Joint International Society for Clinical Densitometry & International Osteoporosis Foundation Position Development Conference

(2011) Jane A. Cauley et al.   JOURNAL OF CLINICAL DENSITOMETRY

Official Positions for FRAX® Bone Mineral Density and FRAX® Simplification

(2011) E. Michael Lewiecki et al.   JOURNAL OF CLINICAL DENSITOMETRY

Official Positions for FRAX® Clinical Regarding Falls and Frailty: Can Falls and Frailty be Used in FRAX®?

(2011) Tahir Masud et al.   JOURNAL OF CLINICAL DENSITOMETRY

Methods for Assessing Fracture Risk Prediction Models: Experience With FRAX in a Large Integrated Health Care Delivery System

(2011) Alice R. Pressman et al.   JOURNAL OF CLINICAL DENSITOMETRY

Diferencias en los valores predictivos de la herramienta FRAX™ entre población española y del Reino Unido y consideraciones sobre el umbral de intervención

(2011) Rafael Azagra et al.   MEDICINA CLINICA

Pitfalls in the external validation of FRAX

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

High fracture probability with FRAX® usually indicates densitometric osteoporosis: implications for clinical practice

(2011) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

Guidance for the adjustment of FRAX according to the dose of glucocorticoids

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Interpretation and use of FRAX in clinical practice

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Secular trends in the incidence of hip and other osteoporotic fractures

(2011) C. Cooper et al.   OSTEOPOROSIS INTERNATIONAL

Fracture risk assessment without bone density measurement in routine clinical practice

(2011) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

Fracture risk assessed by Fracture Risk Assessment Tool (FRAX) compared with fracture risk derived from population fracture rates

(2011) Katrine Hass Rubin et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.—Conformity between methods and their clinical utility

(2010) W. Pluskiewicz et al.   BONE

Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer

(2010) M. Ivergård et al.   BONE

FRAX® and its applications in health economics—Cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example

(2010) O. Ström et al.   BONE

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

(2010) A. Papaioannou et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort

(2010) Elisabeth Sornay-Rendu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Independent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibration

(2010) William D Leslie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: Sensitivity of the WHO FRAX tool

(2010) Florence A Trémollieres et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Evaluation of the FRAX and Garvan fracture risk calculators in older women

(2010) Mark J Bolland et al.   JOURNAL OF BONE AND MINERAL RESEARCH

EMAS position statement: Bone densitometry screening for osteoporosis

(2010) Mark Brincat et al.   MATURITAS

Management of osteoporosis in postmenopausal women

(2010) &NA;   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos

(2010) L.-A. Fraser et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective

(2010) F. Borgström et al.   OSTEOPOROSIS INTERNATIONAL

A FRAX® model for the assessment of fracture probability in Belgium

(2010) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Spine–hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement

(2010) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

(2010) B. Jönsson et al.   OSTEOPOROSIS INTERNATIONAL

Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts

(2010) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

A Comparison of Three Different Guidelines for Osteoporosis Treatment in Patients with Rheumatoid Arthritis in Korea

(2010) Jiyeol Yoon et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women

(2010) John A. Kanis et al.   Archives of Osteoporosis

Assessment of Individual Fracture Risk: FRAX and Beyond

(2010) Joop P. W. van den Bergh et al.   Current Osteoporosis Reports

Screening for Osteoporosis in the Adult U.S. Population

(2009) Lionel S. Lim et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

A Comparison of Prediction Models for Fractures in Older Women

(2009) Kristine E. Ensrud   ARCHIVES OF INTERNAL MEDICINE

FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial

(2009) Meghan G Donaldson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

(2009) J. Compston et al.   MATURITAS

Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study

(2009) S. D. Berry et al.   OSTEOPOROSIS INTERNATIONAL

The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis

(2009) F. Borgström et al.   OSTEOPOROSIS INTERNATIONAL

The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®

(2009) F. Borgström et al.   OSTEOPOROSIS INTERNATIONAL

Can fall risk be incorporated into fracture risk assessment algorithms: a pilot study of responsiveness to clodronate

(2009) K. Kayan et al.   OSTEOPOROSIS INTERNATIONAL

The effects of a FRAX® revision for the USA

(2009) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX™

(2009) R. A. Adler et al.   OSTEOPOROSIS INTERNATIONAL

BMD, clinical risk factors and their combination for hip fracture prevention

(2009) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Prognosis of fracture: evaluation of predictive accuracy of the FRAX™ algorithm and Garvan nomogram

(2009) S. K. Sandhu et al.   OSTEOPOROSIS INTERNATIONAL

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

(2009) B. Dawson-Hughes et al.   OSTEOPOROSIS INTERNATIONAL

Vertebral Fracture Status and the World Health Organization Risk Factors for Predicting Osteoporotic Fracture Risk*

(2008) Peiqi Chen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A Revised Clinician’s Guide to the Prevention and Treatment of Osteoporosis

(2008) Bess Dawson-Hughes   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)

(2008) S. Fujiwara et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effective osteoporosis treatment thresholds: the United States perspective

(2008) A. N. A. Tosteson et al.   OSTEOPOROSIS INTERNATIONAL

Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks

(2008) N. D. Nguyen et al.   OSTEOPOROSIS INTERNATIONAL

The cost-effectiveness of alendronate in the management of osteoporosis

(2007) John A. Kanis et al.   BONE